Bristol-Myers Squibb has appointed Murdo Gordon to the newly-created position of executive vice president and chief commercial officer.
In this new role, Gordon will have responsibility for the New York-headquartered firm’s global commercial strategy, as well as its new worldwide commercialisation team. He will report directly to BMS’ chief executive Giovanni Caforio.
Gordon has nearly 30 years of industry experience with the biopharma company, having first joined its Canadian operations in 1989, where he held positions of increasing responsibility, including vice president of marketing, before moving to the US in 2003.
There he worked in a number of senior commercial leadership posts across the cardiovascular and neuroscience therapeutic areas, as well as in market access.
He was promoted to president of BMS’ US operations in 2013, before taking on his most recent role as head of worldwide markets in January last year.
Gordon currently also serves a member of the board of directors for RWJBarnabas Health, a New Jersey-based comprehensive healthcare services provider.